Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hampig Raphael Kourie

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Pharmacogenomics|November 3, 2021
Poly(ADP-ribose) polymerase inhibitors in prostate cancer: a cornerstone in precision oncologyTalal Ziadeh, Hampig Raphael Kourie
Immunotherapy|June 29, 2016
Immune checkpoint inhibitors side effects and managementHampig Raphael Kourie, Jean Klastersky
Investigational New Drugs|March 11, 2016
Why balls are not put inside the basket? A reflection on testicular cancer clinical trial designHampig Raphael Kourie, Fouad Aoun
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2023
Updates in the Management of Primary Mediastinal B Cell LymphomaCharbel Soueidy, Hampig Raphael Kourie
Current Opinion in Oncology|May 3, 2017
Physical long-term side-effects in young adult cancer survivors: germ cell tumors modelHampig Raphael Kourie, Jean A Klastersky
Critical Reviews in Oncology/Hematology|March 19, 2021
Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue seaMarc Boutros, Elissar Moujaess, Hampig Raphael Kourie
Immunotherapy|January 5, 2023
Adjuvant therapy in renal cell carcinoma in the immunotherapy era: where do we stand?Joseph Zouein, Nabih Naim, Hampig Raphael Kourie
Critical Reviews in Oncology/Hematology|April 29, 2020
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidenceElissar Moujaess, Hampig Raphael Kourie, Marwan Ghosn
World Journal of Gastroenterology|August 1, 2015
Gastrointestinal cancers in the era of theranostics: Updates and future perspectivesMarwan Ghosn, Hampig Raphael Kourie, Samer Tabchi
Chinese Journal of Cancer|January 15, 2017
Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature reviewAurélien Simon, Hampig Raphael Kourie, Joseph Kerger
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Pharmacogenomics|November 3, 2021
Poly(ADP-ribose) polymerase inhibitors in prostate cancer: a cornerstone in precision oncologyTalal Ziadeh, Hampig Raphael Kourie
Immunotherapy|June 29, 2016
Immune checkpoint inhibitors side effects and managementHampig Raphael Kourie, Jean Klastersky
Investigational New Drugs|March 11, 2016
Why balls are not put inside the basket? A reflection on testicular cancer clinical trial designHampig Raphael Kourie, Fouad Aoun
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2023
Updates in the Management of Primary Mediastinal B Cell LymphomaCharbel Soueidy, Hampig Raphael Kourie
Current Opinion in Oncology|May 3, 2017
Physical long-term side-effects in young adult cancer survivors: germ cell tumors modelHampig Raphael Kourie, Jean A Klastersky
Critical Reviews in Oncology/Hematology|March 19, 2021
Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue seaMarc Boutros, Elissar Moujaess, Hampig Raphael Kourie
Immunotherapy|January 5, 2023
Adjuvant therapy in renal cell carcinoma in the immunotherapy era: where do we stand?Joseph Zouein, Nabih Naim, Hampig Raphael Kourie
Critical Reviews in Oncology/Hematology|April 29, 2020
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidenceElissar Moujaess, Hampig Raphael Kourie, Marwan Ghosn
World Journal of Gastroenterology|August 1, 2015
Gastrointestinal cancers in the era of theranostics: Updates and future perspectivesMarwan Ghosn, Hampig Raphael Kourie, Samer Tabchi
Chinese Journal of Cancer|January 15, 2017
Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature reviewAurélien Simon, Hampig Raphael Kourie, Joseph Kerger
Pageof 13